Journal
JOURNAL OF PROTEOMICS
Volume 191, Issue -, Pages 48-57Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.jprot.2018.04.021
Keywords
Tumor antigens; Mass spectrometry; Next generation sequencing; Bioinformatics; Cancer immunology
Categories
Ask authors/readers for more resources
The field of cancer immunotherapy has expanded rapidly in the past few years, with many new approaches entering the clinic for T cell mediated killing of tumors. Several of these clinical approaches involve the exploitation of a CD8 + T cell response against MHC I presented tumor antigens. Here, we describe the types of tumor antigens which are considered as targets in the design of T cell based therapeutic approaches, the rationale for targeting MHC I antigens and the analytical tools commonly employed for the discovery of MHC I presented peptides. The advantages and disadvantages of each approach are discussed and a perspective on the future directions of the MHC I peptide exploration field and biotherapeutic strategies is given. Significance: This work is the first time a review article has been written to summarize all the various types of tumor antigens, and the analytical tools employed to discover and characterize them.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available